According to a study published, sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes may prevent dementia, with higher advantages with prolonged treatment.
A quarter-sized device created at Houston Methodist could drastically alter the course of treatment for Type 1 diabetes, a chronic condition that impacts millions of Americans and does not have a cure.